Chandra Prasad

Dr. Chandra Prasad

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2019 in Translational Lung Cancer Research
Verified
Journal Article
Closed access
PDF file
ASAbhishek Shankar
Abhishek Shankar
ADAnusha Dubey
Anusha Dubey
DSDeepak Saini
Deepak Saini
MSMayank Singh
Mayank Singh
Chandra PrasadChandra Prasad
Chandra Prasad
GRGoura Kishor Rath
Goura Kishor Rath
Lung cancer has become a global problem, from a rare disease to an emerging public health issue. The current data of GLOBOCAN 2018, indicates that this disease has recorded highest mortality among all types of cancer. The etiological factors of lung cancer have become more multiplex because of increasing industrialization and environmental pollution around the world, especially in India. There is a rise in incidence of lung cancer among non-smokers and this can be attributed to environmental and occupational exposure to various kinds of hazardous substances. Target mutations are high in Lung cancer among non-smokers when compared to smokers. Some developed countries have guidelines and policies for prevention and control of risk factors focusing on these issues. Intervention aiming for primary prevention can be an important and cost-effective tool in developing countries to deal with increasing incidence of lung cancer. There is a need to define high risk group among non-smokers after taking into account environmental and occupational determinants as important risk factors. Research on etiology of lung cancer and prevention provides evidence to work on global incidence and prevalence of lung cancer, and for designing cost effective lung cancer prevention strategies. Research in the area of lung cancer prevention should be considered to recognize the areas where action is required to prevent environment and occupation related lung cancer. The government and occupational health and safety organizations have taken many steps in the last few years that can help to protect workers from these exposures. But the dangers are still there, so there is a need to do more to limit these exposures around workplace. This whole situation guides us to advocate population-based intervention along with policy implementation.

1 October 2009 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
Chandra PrasadChandra Prasad
Chandra Prasad
GRGayatri Rath
Gayatri Rath
SMSandeep Mathur
Sandeep Mathur
DBDinesh Bhatnagar
Dinesh Bhatnagar
RRRanju Ralhan
Ranju Ralhan

14 September 2009 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Chandra PrasadChandra Prasad
Chandra Prasad
GRGayatri Rath
Gayatri Rath
SMSandeep Mathur
Sandeep Mathur
DBDinesh Bhatnagar
Dinesh Bhatnagar
RPRajinder Parshad
Rajinder Parshad
RRRanju Ralhan
Ranju Ralhan
Background: Cancer progression is linked to a partially dedifferentiated epithelial cell phenotype. The signaling pathways Wnt, Hedgehog, TGF-β and Notch have been implicated in experimental and developmental epithelial mesenchymal transition (EMT). Recent findings from our laboratory confirm that active Wnt/β-catenin signaling is critically involved in invasive ductal carcinomas (IDCs) of breast. Methods: In the current study, we analyzed the expression patterns and relationships between the key Wnt/β-catenin signaling components- E-cadherin, Slug and GSK3β in IDCs of breast. Results: Of the 98 IDCs analyzed, 53 (54%) showed loss/or reduced membranous staining of E-cadherin in tumor cells. Nuclear accumulation of Slug was observed in 33 (34%) IDCs examined. Loss or reduced level of cytoplasmic GSK3β expression was observed in 52/98 (53%) cases; while 34/98 (35%) tumors showed nuclear accumulation of GSK3β. Statistical analysis revealed associations of nuclear Slug expression with loss of membranous E-cadherin (p = 0.001); nuclear β-catenin (p = 0.001), and cytoplasmic β-catenin (p = 0.005), suggesting Slug mediated E-cadherin suppression via the activation of Wnt/β-catenin signaling pathway in IDCs. Our study also demonstrated significant correlation between GSK3β nuclear localization and tumor grade (p = 0.02), suggesting its association with tumor progression. Conclusion: The present study for the first time provided the clinical evidence in support of Wnt/β-catenin signaling upregulation in IDCs and key components of this pathway - E-cadherin, Slug and GSK3β with β-catenin in implementing EMT in these cells.

1 July 2007 in Life Sciences
Verified
Journal Article
Closed access
SMSameer Mirza
Sameer Mirza
GSGayatri Sharma
Gayatri Sharma
Chandra PrasadChandra Prasad
Chandra Prasad
RPRajinder Parshad
Rajinder Parshad
ASAnurag Srivastava
Anurag Srivastava
RRRanju Ralhan
Ranju Ralhan

1 July 2008 in Life Sciences
Verified
Journal Article
Closed access
Chandra PrasadChandra Prasad
Chandra Prasad
SMSameer Mirza
Sameer Mirza
GSGayatri Sharma
Gayatri Sharma
RPRajinder Prashad
Rajinder Prashad
SDSiddhartha DattaGupta
Siddhartha DattaGupta
RRRanju Ralhan
Ranju Ralhan

1 May 2019 in Translational Lung Cancer Research
Verified
Journal Article
Closed access
PDF file
ASAbhishek Shankar
Abhishek Shankar
DSDeepak Saini
Deepak Saini
ADAnusha Dubey
Anusha Dubey
SRShubham Roy
Shubham Roy
SBSachidanand Jee Bharati
Sachidanand Jee Bharati
GRGoura Kishor Rath
Goura Kishor Rath
Lung cancer is the leading cause of all cancer deaths worldwide, comprising 18.4% of all cancer deaths. Low-dose computed tomography (LDCT) has shown mortality benefit in various trials and now a standard tool for lung cancer screening. Most researches have been carried out in developed countries where lung cancer incidence and mortality is very high. There is an increasing trend in lung cancer incidence in developing countries attributed to tobacco smoking and various environmental and occupational risk factors. Implementation of lung cancer screening is challenging, so organised lung cancer screening is practically non-existent. There are numerous challenges in implementing such programs ranging from infrastructure, trained human resources, referral algorithm to cost and psychological trauma due to over-diagnosis. Pulmonary tuberculosis and other chest infections are important issues to be addressed while planning for lung cancer screening in developing countries. Burden of these diseases is very high and can lead to over-diagnosis in view of cut off of lung nodule size in various studies. Assessment of high risk cases for lung cancer is difficult as various forms of smoking make quantification non-uniform and difficult. Lung cancer screening targets only high risk population unlike screening programs for other cancers where entire population is targeted. There is a need of lung cancer screening for high risk cases as it saves life. Tobacco control and smoking cessation remain the most important long term intervention to decrease morbidity and mortality from lung cancer in developing countries. There is no sufficient evidence supporting the introduction of population-based screening for lung cancer in public health services.